Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. - Batist,G..; Ramakrishnan,G..; Rao,C.S.; et,al.. (J Clin Oncol, 2001)